1. Home
  2. BEAM vs SIMO Comparison

BEAM vs SIMO Comparison

Compare BEAM & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$26.88

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$88.85

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
SIMO
Founded
2017
1995
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
3.2B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
BEAM
SIMO
Price
$26.88
$88.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
8
Target Price
$48.09
$103.13
AVG Volume (30 Days)
2.0M
326.7K
Earning Date
11-04-2025
02-04-2026
Dividend Yield
N/A
2.25%
EPS Growth
N/A
8.75
EPS
N/A
2.87
Revenue
$55,701,000.00
$798,326,000.00
Revenue This Year
N/A
$10.15
Revenue Next Year
$26.52
$17.72
P/E Ratio
N/A
$30.93
Revenue Growth
N/A
N/A
52 Week Low
$13.53
$37.21
52 Week High
$35.25
$106.60

Technical Indicators

Market Signals
Indicator
BEAM
SIMO
Relative Strength Index (RSI) 56.10 49.01
Support Level $25.53 $83.34
Resistance Level $27.87 $89.26
Average True Range (ATR) 1.64 3.24
MACD -0.03 -0.26
Stochastic Oscillator 61.06 41.03

Price Performance

Historical Comparison
BEAM
SIMO

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: